The Perimenopausal Aging Transition in the Female Rat Brain: Decline in Bioenergetic Systems and Synaptic Plasticity
Total Page:16
File Type:pdf, Size:1020Kb
Neurobiology of Aging 36 (2015) 2282e2295 Contents lists available at ScienceDirect Neurobiology of Aging journal homepage: www.elsevier.com/locate/neuaging The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity Fei Yin a, Jia Yao a, Harsh Sancheti a, Tao Feng b, Roberto C. Melcangi c, Todd E. Morgan d, Caleb E. Finch d, Christian J. Pike d, Wendy J. Mack b, Enrique Cadenas a, Roberta D. Brinton a,e,* a Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA, USA b Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA c Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy d Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA e Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA article info abstract Article history: The perimenopause is an aging transition unique to the female that leads to reproductive senescence Received 19 December 2014 which can be characterized by multiple neurological symptoms. To better understand potential under- Received in revised form 20 February 2015 lying mechanisms of neurological symptoms of perimenopause, the present study determined genomic, Accepted 25 March 2015 biochemical, brain metabolic, and electrophysiological transformations that occur during this transition Available online 1 April 2015 using a rat model recapitulating fundamental characteristics of the human perimenopause. Gene expression analyses indicated two distinct aging programs: chronological and endocrine. A critical period Keywords: emerged during the endocrine transition from regular to irregular cycling characterized by decline in Perimenopause fi fi fl e Female brain aging bioenergetic gene expression, con rmed by de cits in uorodeoxyglucose positron emission tomog- Glucose metabolism raphy (FDG-PET) brain metabolism, mitochondrial function, and long-term potentiation. Bioinformatic Mitochondria analysis predicted insulin/insulin-like growth factor 1 and adenosine monophosphate-activated protein Synaptic plasticity kinase/peroxisome proliferator-activated receptor gamma coactivator 1 alpha (AMPK/PGC1a) signaling Hypometabolism pathways as upstream regulators. Onset of acyclicity was accompanied by a rise in genes required for Fatty acid metabolism fatty acid metabolism, inflammation, and mitochondrial function. Subsequent chronological aging Long-term potentiation resulted in decline of genes required for mitochondrial function and b-amyloid degradation. Emergence of glucose hypometabolism and impaired synaptic function in brain provide plausible mechanisms of neurological symptoms of perimenopause and may be predictive of later-life vulnerability to hypo- metabolic conditions such as Alzheimer’s. Ó 2015 Elsevier Inc. All rights reserved. 1. Introduction complete decrease in ovarian secretion of estrogen and progester- one hormones (Harlow et al., 2012). Similar to the human, rodent The perimenopause, unique to the female, is a midlife transition and nonhuman primates share common features of the perimen- state that precedes and leads to reproductive senescence (Brinton, opausal transition, including decline in follicles, irregular cycling, 2010; Butler and Santoro, 2011). Worldwide, there are currently irregular fertility, steroid hormone fluctuations, and insensitivity to >850 million women aged 40e60 years, 88% of whom will transi- estrogen (Brinton, 2012; Finch, 2014). tion through the perimenopause by age 55; all women who reach Although the clinical definition of perimenopause focuses on the age of 60 with reproductive organs intact will transition functional changes in the reproductive system, the symptoms of the through the perimenopause to the menopause (Brinton, 2010; perimenopause are largely neurological in nature. The breadth of Harlow et al., 2012). This final stage is associated with a near neurological symptoms coincident with the perimenopause is well documented in the clinical science literature (Genazzani et al., 2005; Greendale et al., 2010; Maki et al., 2008; Nelson, 2008). These neurological symptoms including increased temperature, * Corresponding author at: Department of Pharmacology and Pharmaceutical depression, insomnia, pain, and cognitive impairment during the Sciences, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, PSC-502, Los Angeles, CA 90089, USA. Tel.: 323 442 1436; fax: 323 442 1740. perimenopausal transition are indicative of disruption in multiple E-mail address: [email protected] (R.D. Brinton). systems, whereas their emergence during the same transition is 0197-4580/$ e see front matter Ó 2015 Elsevier Inc. All rights reserved. http://dx.doi.org/10.1016/j.neurobiolaging.2015.03.013 F. Yin et al. / Neurobiology of Aging 36 (2015) 2282e2295 2283 indicative of a common or a set of common underlying mecha- and irregular 9e10 month groups (20 rats in total) was used for LTP nisms. Substantial evidence indicates that ovarian and neural hor- (Fig. 6). Rats that did not meet the endocrine criteria for each group mones including 17b-estradiol (E2) and progesterone (P4) regulate were excluded from analyses for this study. fundamental systems in brain at both the organizational and acti- vational levels including neurogenesis, cell survival, brain meta- 2.2. Brain tissue collection bolism, neuroinflammation, and synaptic activity (Brinton, 2008, 2009; Brinton et al., 2008; McEwen et al., 2012; Morrison et al., Rats were euthanized and the brains rapidly dissected on ice. 2006; Rettberg et al., 2014; Simpkins et al., 2010; Woolley, 2007; Cerebellum and brain stem were removed from each brain and two Yao et al., 2011). hemispheres were separated. The cortical hemisphere was fully The present perimenopause model builds on prior studies in peeled laterally and hippocampus was then separated. Both cortex middle-aged rats during their transition from regular to irregular and hippocampus were harvested and frozen in À80 C for subse- cycling (Adams et al., 2001; Downs and Wise, 2009; Finch et al., quent analyses. 1984; Gore et al., 2000; Kermath and Gore, 2012). The transition to irregular cycles was associated with cognitive impairments and 2.3. Quantitative analysis of steroid hormones by liquid altered sex steroids in hippocampus and cerebral cortex (Paris et al., chromatography-tandem mass spectrometry (LC-MS/MS) 2011), while we found altered expression of estrogen receptor a (ERa) in astrocytes of cerebral cortex with altered neurotrophic Levels of P4 and E2 extracted from cerebral cortex and serum were activity in vitro (Arimoto et al., 2013). To investigate potential measured as previously described (Caruso et al., 2013). 2,2,4,6,6- underlying mechanisms of neurological dysfunction during the 17a,21,21,21-D9-PROG (D9-PROG) was obtained from Medical Iso- perimenopause, we conducted neural analyses in endocrine- topes, (Pelham, NH, USA); 2,3,4e13C3-17b-estradiol (13C3-17b-E) was characterized rats spanning the transition from reproductively obtained from Sigma-Aldrich. Solid phase extraction (SPE) cartridges capable to reproductive senescent to aged. Using this model, we (Discovery DS-C18 500 mg) were from Supelco, Italy. Cerebral cortex investigated the differential impact of endocrine aging versus and serum were spiked with 13C3-17b-E (1 ng/sample) and D9-PROG chronological aging on hippocampal bioenergetic systems (glucose (0.2 ng/sample), as internal standards and homogenized in 2 mL of metabolism, inflammation, redox, lipid metabolism, and b-amyloid MeOH to acetic acid (99:1 vol/vol). After an overnight extraction at 4 processing) and synaptic function (long-term potentiation [LTP]). C, samples were centrifuged at 12,000 rpm for 5 minutes, and the Findings from this study revealed bioenergetic transitions specific pellet was extracted twice with 1 mL of MeOH to acetic acid (99:1 vol/ to endocrine aging during the perimenopause, that were coincident vol). The organic phases were combined and evaporated to dryness. with significant decline in synaptic plasticity. The organic residues were resuspended with 3 mL of MeOH to H2O (10:90 vol/vol) and passed through an SPE cartridge, previously acti- 2. Methods vated with MeOH (5 mL) and MeOH:H2O 1:9 vol/vol (5 mL), the ste- roids were eluted in MeOH. Quantitative analysis was performed on 2.1. Animals the basis of calibration curves daily prepared and analyzed. Positive atmospheric pressure chemical ionization experiments were per- Animal studies were performed following National Institutes of formed with a linear ion trapemass spectrometer (LTQ, Thermo- Health guidelines on use of laboratory animals; protocols were Electron Co, San Jose, CA, USA) using nitrogen as sheath, auxiliary, and approved by the Universityof Southern CaliforniaInstitutional Animal sweep gas. The mass spectrometer (MS) was employed in tandem Care and Use Committee. A total of 90 young or middle-aged female mode (MS/MS) using helium as collision gas. The Hypersil GOLD Sprague-Dawley rats were obtained from Harlan Laboratories. Regu- column (100 Â 3mm,3mm; ThermoElectron Co) wasmaintained at40 lar 6-month group was cycled from 5 months of age using rats that had C. Peaks of the LC-MS/MS were evaluated by means of the software given birth to at least 1 litter. Rats for all other groups were aged from Excalibur release 2.0 SR2. The steroids